Guizhou Xinbang Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2021: 0.01%

Guizhou Xinbang Pharmaceutical Co Ltd (002390) has an Asset Resilience Ratio of 0.01% as of September 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.00 Million

≈ $146.33K USD Cash + Short-term Investments

Total Assets

CN¥9.61 Billion

≈ $1.41 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2017)

This chart shows how Guizhou Xinbang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check how strategically is Guizhou Xinbang Pharmaceutical Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Guizhou Xinbang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Guizhou Xinbang Pharmaceutical Co Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.00 Million	0.01%
Total Liquid Assets	CN¥1.00 Million	0.01%

Asset Resilience Insights

Limited Liquidity: Guizhou Xinbang Pharmaceutical Co Ltd maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guizhou Xinbang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guizhou Xinbang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.62%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	Drug Manufacturers - Specialty & Generic	5.22%
Humanwell Healthcare Group Co Ltd SHG:600079	Drug Manufacturers - Specialty & Generic	2.75%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Guizhou Xinbang Pharmaceutical Co Ltd (2012–2017)

The table below shows the annual Asset Resilience Ratio data for Guizhou Xinbang Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2017-12-31	0.67%	CN¥80.00 Million ≈ $11.71 Million	CN¥11.95 Billion ≈ $1.75 Billion	-0.63pp
2016-12-31	1.30%	CN¥140.00 Million ≈ $20.49 Million	CN¥10.80 Billion ≈ $1.58 Billion	+0.53pp
2015-12-31	0.77%	CN¥50.00 Million ≈ $7.32 Million	CN¥6.50 Billion ≈ $951.87 Million	+0.86pp
2014-12-31	-0.10%	CN¥-4.99 Million ≈ $-729.90K	CN¥5.22 Billion ≈ $764.33 Million	-5.48pp
2013-12-31	5.38%	CN¥80.00 Million ≈ $11.71 Million	CN¥1.49 Billion ≈ $217.54 Million	+3.88pp
2012-12-31	1.50%	CN¥20.00 Million ≈ $2.93 Million	CN¥1.33 Billion ≈ $195.30 Million	--

pp = percentage points

About Guizhou Xinbang Pharmaceutical Co Ltd

SHE:002390 China Drug Manufacturers - Specialty & Generic

Market Cap

$787.92 Million

CN¥5.38 Billion CNY

Market Cap Rank

#10088 Global

#2689 in China

Share Price

CN¥2.77

Change (1 day)

+1.09%

52-Week Range

CN¥2.60 - CN¥4.15

All Time High

CN¥14.40